case-reports-2018-keynote

3 / 6

Medical Case Reports
ISSN: 2471-8041
May 28-29, 2018
London, UK
Case Reports 2018
Page 17
8th Edition of International Conference on
Clinical and Medical Case Reports
“1 Indian dies of tuberculosis every minute” as late as August
1, 2017. Tuberculosis kills one person every 18 seconds,
worldwide.
What has been done, -and not done-, to achieve this result?
Who recommended the policy that generated this disaster? It
shouldn’t be contentious that an organization or an academic
set up to give you advice should have to be told that the advice
has to be good for you. An adversarial relationship with the truth
about tuberculosis materialized as early as the 1950’s with the
inexcusable, appalling promotion by theWHO of the BCG vaccine
knownbytheWHOtobeiatrogenicandendedupinanunmitigated
disaster with the Revised National Tuberculosis Control Program
(RNTCP) initiated by India in 2011. The present communication
focuses on tuberculosis blood tests. Counseled by Mc Gill
University and WHO , the Indian Ministry of Health banned in
2012 the use, import, sale and manufacture of antibody-based
blood tests for TB. Yet, the All India Institute of Medical Sciences
(AIIMS) published in 2017 the results it obtained by a blood test
for TB that it had developed. These results are identical to those
obtained by the Anda TB test banned in 2012. This absolute
identity in results proves the accuracy -and also the usefulness
and value- of the banished product. The ban was a dishonor for
the IndianMinistry of Health, a sin against science andmedicine,
and a felony for the Indian TB patients and their physicians
abruptly deprived of an exceptionally useful diagnostic and
prognostic tool.
Where is the war on TB heading to?
Knowledge of the past allows building informed opinion and
affects how we respond to a contemporary issue. The book “Is
tuberculosisournewchallenge?” (LambertAcademicPublishing,
2016) 1 exposes howspecial interests rigged theTB care system
for six+ decades, worldwide. The TV channel ARTE denounced
on April 4th 2017 (“The WHO in the claws of lobbyists?”) the
corruption of the TB section of the WHO, to the detriment of
patients. Yet, doom is not imperative for Tuberculosis: the
dismal past and alarming present should not specify the future.
There are means available that may help in the immediate
turn. For example, the food supplement pau aspido (Parabolic
biologicals) stimulates very efficiently in a non-specific way the
immune defenses of the organism. This immunotherapy works,
is without side effects, is affordable and the above-mentioned
publication demonstrates how beneficial such a boost may be
for TB patients. It was proposed to WHO in 2014 and snubbed.
For the sake of the patients, use it without delay, right now. It will
help save many lives tampered with an overdose of crippling
specific drugs. We need a revolution inTB care but this will occur
only in a major crisis when we will recognize that the war on TB,
if pursued along the lines now followed, is lost.
Biography
Roland Maes was born in 1935 in Belgium. After acquiring a degree in zo-
ology at the Catholic University of Louvain (Belgium), he studied virology at
the Max Planck Institute for Virus Research (Tübingen, Germany) and at
the Wistar Institute of Anatomy (Philadelphia, USA). He moved thereafter
shortly to Brussels (European Headquarters of Travenol) and then to Stras-
bourg, where he was active at the Richardson-Merrel Research institute. He
resolved to create his own company in Strasbourg, working mainly on the
development of diagnostic tools for tuberculosis and on alternative medi-
cine. This occupation put him in close contact with developing countries of
the Asian and African continent.R. Maes is the author of numerous scien-
tific publications.”
TB blood tests revisited
Roland Maes
Anda Biologicals,Paris
Roland Maes, Med Case Rep. 2018, Volume 4
DOI:10.21767/2471-8041-C1-001